Interferon-α nasal spray was safe and effective in reducing COVID-19 risk by 40% in patients with cancer, demonstrating its potential as an additional preventive strategy alongside vaccines and ...
Interferons can stimulate early antiviral immunity. In this platform trial, a single dose of pegylated interferon lambda given early was associated with decreased progression to more severe Covid-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results